G Medical Innovations Holdings Ltd. (GMVD): Price and Financial Metrics
GET POWR RATINGS... FREE!
GMVD Stock Price Chart Interactive Chart >
GMVD Price/Volume Stats
| Current price | $2.28 | 52-week high | $5.50 |
| Prev. close | $2.35 | 52-week low | $0.14 |
| Day low | $2.23 | Volume | 161,900 |
| Day high | $2.39 | Avg. volume | 725,508 |
| 50-day MA | $2.99 | Dividend yield | N/A |
| 200-day MA | $2.00 | Market Cap | N/A |
G Medical Innovations Holdings Ltd. (GMVD) Company Bio
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiogram data continuously for up to 14 days. It also develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. G Medical Innovations Holdings Ltd was founded in 2014 and is based in Rehovot, Israel.
Latest GMVD News From Around the Web
Below are the latest news stories about G Medical Innovations Holdings Ltd that investors may wish to consider to help them evaluate GMVD as an investment opportunity.
56 Biggest Movers From YesterdayCheck out these big penny stock gainers and losers Losers Vera Therapeutics, Inc. (NASDAQ: VERA) shares tumbled 26.5% to settle at $22.48. MacroGenics, Inc. (NASDAQ: MGNX) fell 23.8% to close at $20.99 as the company disclosed results from Cohort A Part 1 of the Phase 2/3 MAHOGANY clinical trial of margetuximab. Silverback Therapeutics, Inc. (NASDAQ: SBTX) shares dipped 23.1% to close at $12.50 on Thursday. The company presented interim clinical results from a Phase 1/1b clinical study of SBT605 |
Medical Monitoring Technology Infrastructure Brings G Medical's Telehealth Solution to Next Level of CarePhoto by Patty Brito on Unsplash Although the pandemic brought healthcare to every person’s mind and heart, taking care of yourself, and seeking medical care to stay healthy isn’t exactly a new thing. But with the advancements in technology, health monitoring and care continues to expand to include home care, virtual visits, and online tracking. Now, you no longer have to leave your house to receive professional care, saving money and time for yourself while also reducing the costs associated wi |
G Medical Innovations Holdings Ltd. Reports Financial Results for the Six Months Ended June 30, 2021, with Revenue up 45.5%Demand for patient monitoring services recovering with revenue increasing 45.5% in first half of 2021 Accelerating growth strategy with expansion of Prizma and Cardiac sales team UnityPoint Prizma vital signs pilot study to start end of September; new cardiac services program underway Continued focus on inorganic growth strategy via synergistic acquisitions Strengthened balance sheet with initial public offering (“IPO”) raising gross proceeds of $15.0 million TEL AVIV and ILLINOIS, September 15, |
Mid-Morning Market Update: Markets Mixed; Industrial Production Rises 0.4% In AugustFollowing the market opening Wednesday, the Dow traded up 0.13% to 34,621.78 while the NASDAQ fell 0.25% to 14,999.72. The S&P also rose, gaining 0.03% to 4,444.41. The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 41,367,770 cases with around 663,960 deaths. India confirmed a total of at least 33,316,750 cases and 443,490 deaths, while Brazil reported over 21,019,830 COVID-19 cases with 587,790 deaths. In total, there were at least 225,885,010 ca |
G Medical Innovations: The Next Generation of Healthcare for Caregivers and PatientsPhoto by Online Marketing on Unsplash If the coronavirus pandemic taught the world anything, it was how important healthcare is to everyone. With the virus still posing a serious threat, some people may still be reluctant to visit their regular doctors for checkups. Prevent Cancer Foundation released survey results of more than 1,000 respondents that found about 35% of Americans have missed routine cancer screenings due to COVID-19 fears. Additionally, 43% of Americans have missed medical appoin |
GMVD Price Returns
| 1-mo | -22.71% |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
| 2016 | N/A |
Loading social stream, please wait...